Exposure and study reference . | Outcomes of interesta . | Risk of biasb . | ||||||
---|---|---|---|---|---|---|---|---|
Growth . | Infection . | Bowel function . | Obesity, overweight, body composition . | Glucose metabolism and homeostasis . | Lipids . | Microbiota . | ||
Digestible carbohydrates | ||||||||
Glycemic carbohydrates | ||||||||
Chaidez et al (2014)27 (WIC) |
| — | — |
| — | — | — | Some |
Cowin et al (2001)28 (ALSPAC) |
| — | — |
| — |
| — | Low |
DONALD study: | ||||||||
Buyken et al (2008)24 | — | — | — |
| — | — | — | Some |
Herbst et al (2011)32 | — | — | — |
| — | — | — | |
Garden et al (2011)31 | — | — | — |
| — | — | — | Low |
Huus et al (2009)33 | — | — | — |
| — | — | — | Some |
Jardí et al (2019)34 | — | — | — |
| — | — | — | Some |
Generation R Study: | ||||||||
Kiefte de Jong et al (2013)35 | — | — |
| — | — | — | — | Some |
Nguyen et al (2020)41 | — | — | — |
|
|
| — | Low |
Scaglioni et al (2000)43 | — | — | — |
| — | — | — | Some |
Warner et al (2006)49 | — | — | — |
| — | — | — | Low |
Williams and Strobino (2008)50 | — | — | — |
| — |
| — | Some |
SSBs and fruit juice | ||||||||
Byrne et al (2018)25 | — | — | — |
| — | — | — | Some |
Cantoral et al (2016)26 | — | — | — |
| — | — | — | Low |
Dubois et al (2007)30 | — | — | — |
| — | — | — | Low |
ECLS-B study: | ||||||||
DeBoer et al (2013)29 | — | — | — |
| — | — | — | Low |
Shefferly et al (2016)44 |
| — | — |
| — | — | — | Low |
Garden et al (2011)31 | — | — | — |
| — | — | — | Low |
Generation R Study: | ||||||||
Leermakers et al (2015a)37 | — | — | — | — | — |
| — | Low |
Leermakers et al (2015b)36 |
| — | — |
| — | — | — | |
Lim et al (2008)38 | — | — | — |
| — | — | — | Low |
Quah et al (2019)42 | — | — | — |
| — | — | — | Some |
Viva Project study: | ||||||||
Sonneville et al (2015)45 | — | — | — |
| — | — | — | Low |
Wu et al (2021)51 | — | — | — |
| — | — | — | Low |
Warner et al (2006)49 | — | — | — |
| — | — | — | Low |
WIC study: | ||||||||
Chaidez et al (2014)27 |
| — | — |
| — | — | — | Some |
Newby et al (2004)40 |
| — | — |
| — | — | — | Some |
Nondigestible carbohydrates | ||||||||
Dietary fiber | ||||||||
ALSPAC study: | ||||||||
Cowin et al (2001)28 |
| — | — |
| — |
| — | Low |
Tappin et al (2020)46 | — | — |
| — | — | — | — | Low |
Taylor et al (2016)47 | — | — |
| — | — | — | — | Some |
Beyerlein et al (2015)23 | — | — | — | — |
| — | — | Low |
Buyken et al (2008) (DONALD)24 | — | — | — |
| — | — | — | Some |
Jardí et al (2019)34 |
| — | — | — | — | — | — | Some |
Newby et al (2003)39 (WIC) |
| — | — | — | — | — | — | Some |
Generation R Study: | ||||||||
Kiefte de Jong et al (2013)35 | — | — |
| — | — | — | — | Some |
Van Gijssel et al (2016)48 | — | — | — |
|
|
| — | Low |
Williams and Strobino (2008)50 | — | — | — |
| — |
| — | Some |
Nakamura et al (2006)52 (RCT) (2 g/d of fructo-oligosaccharides supplementation or placebo for 6 mo) | < > Weight gain, height, arm circumference during 6 mo |
|
| — | — | — | — | Low |
Waligora-Dupriet et al (2007)53 (RCT) (2 g/d of fructo-oligosaccharides supplementation or placebo for 21 d) | — |
| < > Stool frequency, consistency, and abdominal pain during 28 d | — | — | — | ▼Bifidobacteria and Clostridia levels at 28 d | Some |
Exposure and study reference . | Outcomes of interesta . | Risk of biasb . | ||||||
---|---|---|---|---|---|---|---|---|
Growth . | Infection . | Bowel function . | Obesity, overweight, body composition . | Glucose metabolism and homeostasis . | Lipids . | Microbiota . | ||
Digestible carbohydrates | ||||||||
Glycemic carbohydrates | ||||||||
Chaidez et al (2014)27 (WIC) |
| — | — |
| — | — | — | Some |
Cowin et al (2001)28 (ALSPAC) |
| — | — |
| — |
| — | Low |
DONALD study: | ||||||||
Buyken et al (2008)24 | — | — | — |
| — | — | — | Some |
Herbst et al (2011)32 | — | — | — |
| — | — | — | |
Garden et al (2011)31 | — | — | — |
| — | — | — | Low |
Huus et al (2009)33 | — | — | — |
| — | — | — | Some |
Jardí et al (2019)34 | — | — | — |
| — | — | — | Some |
Generation R Study: | ||||||||
Kiefte de Jong et al (2013)35 | — | — |
| — | — | — | — | Some |
Nguyen et al (2020)41 | — | — | — |
|
|
| — | Low |
Scaglioni et al (2000)43 | — | — | — |
| — | — | — | Some |
Warner et al (2006)49 | — | — | — |
| — | — | — | Low |
Williams and Strobino (2008)50 | — | — | — |
| — |
| — | Some |
SSBs and fruit juice | ||||||||
Byrne et al (2018)25 | — | — | — |
| — | — | — | Some |
Cantoral et al (2016)26 | — | — | — |
| — | — | — | Low |
Dubois et al (2007)30 | — | — | — |
| — | — | — | Low |
ECLS-B study: | ||||||||
DeBoer et al (2013)29 | — | — | — |
| — | — | — | Low |
Shefferly et al (2016)44 |
| — | — |
| — | — | — | Low |
Garden et al (2011)31 | — | — | — |
| — | — | — | Low |
Generation R Study: | ||||||||
Leermakers et al (2015a)37 | — | — | — | — | — |
| — | Low |
Leermakers et al (2015b)36 |
| — | — |
| — | — | — | |
Lim et al (2008)38 | — | — | — |
| — | — | — | Low |
Quah et al (2019)42 | — | — | — |
| — | — | — | Some |
Viva Project study: | ||||||||
Sonneville et al (2015)45 | — | — | — |
| — | — | — | Low |
Wu et al (2021)51 | — | — | — |
| — | — | — | Low |
Warner et al (2006)49 | — | — | — |
| — | — | — | Low |
WIC study: | ||||||||
Chaidez et al (2014)27 |
| — | — |
| — | — | — | Some |
Newby et al (2004)40 |
| — | — |
| — | — | — | Some |
Nondigestible carbohydrates | ||||||||
Dietary fiber | ||||||||
ALSPAC study: | ||||||||
Cowin et al (2001)28 |
| — | — |
| — |
| — | Low |
Tappin et al (2020)46 | — | — |
| — | — | — | — | Low |
Taylor et al (2016)47 | — | — |
| — | — | — | — | Some |
Beyerlein et al (2015)23 | — | — | — | — |
| — | — | Low |
Buyken et al (2008) (DONALD)24 | — | — | — |
| — | — | — | Some |
Jardí et al (2019)34 |
| — | — | — | — | — | — | Some |
Newby et al (2003)39 (WIC) |
| — | — | — | — | — | — | Some |
Generation R Study: | ||||||||
Kiefte de Jong et al (2013)35 | — | — |
| — | — | — | — | Some |
Van Gijssel et al (2016)48 | — | — | — |
|
|
| — | Low |
Williams and Strobino (2008)50 | — | — | — |
| — |
| — | Some |
Nakamura et al (2006)52 (RCT) (2 g/d of fructo-oligosaccharides supplementation or placebo for 6 mo) | < > Weight gain, height, arm circumference during 6 mo |
|
| — | — | — | — | Low |
Waligora-Dupriet et al (2007)53 (RCT) (2 g/d of fructo-oligosaccharides supplementation or placebo for 21 d) | — |
| < > Stool frequency, consistency, and abdominal pain during 28 d | — | — | — | ▼Bifidobacteria and Clostridia levels at 28 d | Some |
Effect direction—beneficial (positive) effect: ▼ (black arrow; statistical significance, P < .05); (gray arrow; statistical nonsignificance, P ≥ .05); negative (not-beneficial) effect: ▲ (black arrow; statistical significance, P < .05);
(gray arrow; statistical insignificance, P ≥ .05); no association/no change: < >; +/– conflicting results.
Risk-of-bias assessment: based on the Mixed Methods Appraisal Tool (see Table S2A and S2B). “Low” risk of bias when ≤1 question was answered with “no” or “can’t tell”; overall risk of bias was considered as of “some concerns” when 2–3 questions were answered with “no” or “can’t tell”; overall risk of bias was considered “high” when 4–5 questions were answered with “no” or “can’t tell.”
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children; %BF, body fat percentage; BMI, body mass index; BMIZ, BMI z score; DONALD, Dortmund Nutritional and Anthropometric Longitudinally Designed Study; ECLS-B, Early Childhood Longitudinal Study, Birth Cohort; FFMIZ, fat-free mass index z score; FMIZ, fat mass index z score; HDL-C, high-density-lipoprotein cholesterol; LDL-C, low-density-lipoprotein cholesterol; RCT, randomized controlled trial; SSB, sugar-sweetened beverage; SSF, sum of skinfolds; T1DM, type 1 diabetes mellitus; TC, total cholesterol; TG, triglycerides; WAZ, weight-for-age z score; WC, waist circumference; WHZ, weight-for-height z score; WIC, Special Supplemental Nutrition Program for Women, Infants, and Children; WLZ, weight-for-length z score.
Exposure and study reference . | Outcomes of interesta . | Risk of biasb . | ||||||
---|---|---|---|---|---|---|---|---|
Growth . | Infection . | Bowel function . | Obesity, overweight, body composition . | Glucose metabolism and homeostasis . | Lipids . | Microbiota . | ||
Digestible carbohydrates | ||||||||
Glycemic carbohydrates | ||||||||
Chaidez et al (2014)27 (WIC) |
| — | — |
| — | — | — | Some |
Cowin et al (2001)28 (ALSPAC) |
| — | — |
| — |
| — | Low |
DONALD study: | ||||||||
Buyken et al (2008)24 | — | — | — |
| — | — | — | Some |
Herbst et al (2011)32 | — | — | — |
| — | — | — | |
Garden et al (2011)31 | — | — | — |
| — | — | — | Low |
Huus et al (2009)33 | — | — | — |
| — | — | — | Some |
Jardí et al (2019)34 | — | — | — |
| — | — | — | Some |
Generation R Study: | ||||||||
Kiefte de Jong et al (2013)35 | — | — |
| — | — | — | — | Some |
Nguyen et al (2020)41 | — | — | — |
|
|
| — | Low |
Scaglioni et al (2000)43 | — | — | — |
| — | — | — | Some |
Warner et al (2006)49 | — | — | — |
| — | — | — | Low |
Williams and Strobino (2008)50 | — | — | — |
| — |
| — | Some |
SSBs and fruit juice | ||||||||
Byrne et al (2018)25 | — | — | — |
| — | — | — | Some |
Cantoral et al (2016)26 | — | — | — |
| — | — | — | Low |
Dubois et al (2007)30 | — | — | — |
| — | — | — | Low |
ECLS-B study: | ||||||||
DeBoer et al (2013)29 | — | — | — |
| — | — | — | Low |
Shefferly et al (2016)44 |
| — | — |
| — | — | — | Low |
Garden et al (2011)31 | — | — | — |
| — | — | — | Low |
Generation R Study: | ||||||||
Leermakers et al (2015a)37 | — | — | — | — | — |
| — | Low |
Leermakers et al (2015b)36 |
| — | — |
| — | — | — | |
Lim et al (2008)38 | — | — | — |
| — | — | — | Low |
Quah et al (2019)42 | — | — | — |
| — | — | — | Some |
Viva Project study: | ||||||||
Sonneville et al (2015)45 | — | — | — |
| — | — | — | Low |
Wu et al (2021)51 | — | — | — |
| — | — | — | Low |
Warner et al (2006)49 | — | — | — |
| — | — | — | Low |
WIC study: | ||||||||
Chaidez et al (2014)27 |
| — | — |
| — | — | — | Some |
Newby et al (2004)40 |
| — | — |
| — | — | — | Some |
Nondigestible carbohydrates | ||||||||
Dietary fiber | ||||||||
ALSPAC study: | ||||||||
Cowin et al (2001)28 |
| — | — |
| — |
| — | Low |
Tappin et al (2020)46 | — | — |
| — | — | — | — | Low |
Taylor et al (2016)47 | — | — |
| — | — | — | — | Some |
Beyerlein et al (2015)23 | — | — | — | — |
| — | — | Low |
Buyken et al (2008) (DONALD)24 | — | — | — |
| — | — | — | Some |
Jardí et al (2019)34 |
| — | — | — | — | — | — | Some |
Newby et al (2003)39 (WIC) |
| — | — | — | — | — | — | Some |
Generation R Study: | ||||||||
Kiefte de Jong et al (2013)35 | — | — |
| — | — | — | — | Some |
Van Gijssel et al (2016)48 | — | — | — |
|
|
| — | Low |
Williams and Strobino (2008)50 | — | — | — |
| — |
| — | Some |
Nakamura et al (2006)52 (RCT) (2 g/d of fructo-oligosaccharides supplementation or placebo for 6 mo) | < > Weight gain, height, arm circumference during 6 mo |
|
| — | — | — | — | Low |
Waligora-Dupriet et al (2007)53 (RCT) (2 g/d of fructo-oligosaccharides supplementation or placebo for 21 d) | — |
| < > Stool frequency, consistency, and abdominal pain during 28 d | — | — | — | ▼Bifidobacteria and Clostridia levels at 28 d | Some |
Exposure and study reference . | Outcomes of interesta . | Risk of biasb . | ||||||
---|---|---|---|---|---|---|---|---|
Growth . | Infection . | Bowel function . | Obesity, overweight, body composition . | Glucose metabolism and homeostasis . | Lipids . | Microbiota . | ||
Digestible carbohydrates | ||||||||
Glycemic carbohydrates | ||||||||
Chaidez et al (2014)27 (WIC) |
| — | — |
| — | — | — | Some |
Cowin et al (2001)28 (ALSPAC) |
| — | — |
| — |
| — | Low |
DONALD study: | ||||||||
Buyken et al (2008)24 | — | — | — |
| — | — | — | Some |
Herbst et al (2011)32 | — | — | — |
| — | — | — | |
Garden et al (2011)31 | — | — | — |
| — | — | — | Low |
Huus et al (2009)33 | — | — | — |
| — | — | — | Some |
Jardí et al (2019)34 | — | — | — |
| — | — | — | Some |
Generation R Study: | ||||||||
Kiefte de Jong et al (2013)35 | — | — |
| — | — | — | — | Some |
Nguyen et al (2020)41 | — | — | — |
|
|
| — | Low |
Scaglioni et al (2000)43 | — | — | — |
| — | — | — | Some |
Warner et al (2006)49 | — | — | — |
| — | — | — | Low |
Williams and Strobino (2008)50 | — | — | — |
| — |
| — | Some |
SSBs and fruit juice | ||||||||
Byrne et al (2018)25 | — | — | — |
| — | — | — | Some |
Cantoral et al (2016)26 | — | — | — |
| — | — | — | Low |
Dubois et al (2007)30 | — | — | — |
| — | — | — | Low |
ECLS-B study: | ||||||||
DeBoer et al (2013)29 | — | — | — |
| — | — | — | Low |
Shefferly et al (2016)44 |
| — | — |
| — | — | — | Low |
Garden et al (2011)31 | — | — | — |
| — | — | — | Low |
Generation R Study: | ||||||||
Leermakers et al (2015a)37 | — | — | — | — | — |
| — | Low |
Leermakers et al (2015b)36 |
| — | — |
| — | — | — | |
Lim et al (2008)38 | — | — | — |
| — | — | — | Low |
Quah et al (2019)42 | — | — | — |
| — | — | — | Some |
Viva Project study: | ||||||||
Sonneville et al (2015)45 | — | — | — |
| — | — | — | Low |
Wu et al (2021)51 | — | — | — |
| — | — | — | Low |
Warner et al (2006)49 | — | — | — |
| — | — | — | Low |
WIC study: | ||||||||
Chaidez et al (2014)27 |
| — | — |
| — | — | — | Some |
Newby et al (2004)40 |
| — | — |
| — | — | — | Some |
Nondigestible carbohydrates | ||||||||
Dietary fiber | ||||||||
ALSPAC study: | ||||||||
Cowin et al (2001)28 |
| — | — |
| — |
| — | Low |
Tappin et al (2020)46 | — | — |
| — | — | — | — | Low |
Taylor et al (2016)47 | — | — |
| — | — | — | — | Some |
Beyerlein et al (2015)23 | — | — | — | — |
| — | — | Low |
Buyken et al (2008) (DONALD)24 | — | — | — |
| — | — | — | Some |
Jardí et al (2019)34 |
| — | — | — | — | — | — | Some |
Newby et al (2003)39 (WIC) |
| — | — | — | — | — | — | Some |
Generation R Study: | ||||||||
Kiefte de Jong et al (2013)35 | — | — |
| — | — | — | — | Some |
Van Gijssel et al (2016)48 | — | — | — |
|
|
| — | Low |
Williams and Strobino (2008)50 | — | — | — |
| — |
| — | Some |
Nakamura et al (2006)52 (RCT) (2 g/d of fructo-oligosaccharides supplementation or placebo for 6 mo) | < > Weight gain, height, arm circumference during 6 mo |
|
| — | — | — | — | Low |
Waligora-Dupriet et al (2007)53 (RCT) (2 g/d of fructo-oligosaccharides supplementation or placebo for 21 d) | — |
| < > Stool frequency, consistency, and abdominal pain during 28 d | — | — | — | ▼Bifidobacteria and Clostridia levels at 28 d | Some |
Effect direction—beneficial (positive) effect: ▼ (black arrow; statistical significance, P < .05); (gray arrow; statistical nonsignificance, P ≥ .05); negative (not-beneficial) effect: ▲ (black arrow; statistical significance, P < .05);
(gray arrow; statistical insignificance, P ≥ .05); no association/no change: < >; +/– conflicting results.
Risk-of-bias assessment: based on the Mixed Methods Appraisal Tool (see Table S2A and S2B). “Low” risk of bias when ≤1 question was answered with “no” or “can’t tell”; overall risk of bias was considered as of “some concerns” when 2–3 questions were answered with “no” or “can’t tell”; overall risk of bias was considered “high” when 4–5 questions were answered with “no” or “can’t tell.”
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children; %BF, body fat percentage; BMI, body mass index; BMIZ, BMI z score; DONALD, Dortmund Nutritional and Anthropometric Longitudinally Designed Study; ECLS-B, Early Childhood Longitudinal Study, Birth Cohort; FFMIZ, fat-free mass index z score; FMIZ, fat mass index z score; HDL-C, high-density-lipoprotein cholesterol; LDL-C, low-density-lipoprotein cholesterol; RCT, randomized controlled trial; SSB, sugar-sweetened beverage; SSF, sum of skinfolds; T1DM, type 1 diabetes mellitus; TC, total cholesterol; TG, triglycerides; WAZ, weight-for-age z score; WC, waist circumference; WHZ, weight-for-height z score; WIC, Special Supplemental Nutrition Program for Women, Infants, and Children; WLZ, weight-for-length z score.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.